Liver Diseases - Medicine | Icahn School of Medicine

Originally led by Hans Popper, MD, “The Father of Modern Hepatology,” the Division of Liver Diseases at Mount Sinai has played a pivotal role in the advancement of hepatology both within and beyond the United States. Today, we continue this legacy within the Department of Medicine at the Icahn School of Medicine at Mount Sinai, where we provide outstanding clinical care, breakthrough research, and comprehensive training programs for the future pioneers of our field.

The Division’s commitment to research has driven several key advances in hepatology. In partnership with the Recanati/Miller Transplantation Institute, in 1988, we were the first to perform a liver transplantation in New York State. Additionally, we developed the first effective oral therapy for liver cancer. We continue to test new therapies every day, striving to rapidly translate discoveries into more effective treatments for a diverse range of liver diseases.

Our multidisciplinary approach to clinical care has made Icahn Mount Sinai a magnet for those seeking personalized treatment for hepatitis B and C virus infections, autoimmune and drug-induced liver disease, hepatic fibrosis, steatotic liver disease (previously known as fatty liver disease), cirrhosis, and liver cancer. By closely collaborating with specialists in transplantation, pathology, radiology, and oncology, we deliver integrative plans that are tailored to each patient's needs. Within the Mount Sinai Health System, we offer advanced treatment at four sites: The Mount Sinai Hospital, Mount Sinai West, Mount Sinai Morningside, and Mount Sinai-Union Square.

We remain equally dedicated to training the next generation of premier hepatologists. The Division’s Transplant Hepatology Fellowship at The Mount Sinai Hospital offers advanced clinical training to applicants who have also completed a gastroenterology fellowship. This program was the first of its kind to be approved by the Accreditation Council for Graduate Medical Education (ACGME) in the Northeast and remains one of the largest such fellowships in the United States.